Symvess acellular tissue engineered vessel for surgical vascular implantation Images
Generic Name: acellular tissue engineered vessel
This medication has been identified as Symvess acellular tissue engineered vessel for surgical vascular implantation. It is supplied by Humacyte Global, Inc.
Symvess is used in the treatment of Revascularization Procedures.
Images of medication
Symvess
- Generic Name
- acellular tissue engineered vessel
- Strength
- acellular tissue engineered vessel for surgical vascular implantation
- CSA Schedule
- Unknown
- Labeler / Supplier
- Humacyte Global, Inc.
- National Drug Code (NDC)
- 83564-0110
See also:
More about Symvess (acellular tissue engineered vessel)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.